The world's first vaccine entirely designed by artificial intelligence, developed by UK scientists, has begun human trials. This marks a significant step in using AI for medical advancements, particularly against coronaviruses.
Scientists in the UK, including those at Oxford, are developing a new Ebola vaccine that could be ready for trials within a few months, leveraging breakthroughs from Covid vaccine development.
UK scientists have found that tocilizumab, a drug used for rheumatoid arthritis, may be effective in treating depression among patients who have not responded to conventional antidepressants, according to early trial results.
A letter from over 65 leading UK scientists urging the abandonment of North Sea oil and gas is being criticized as ideology rather than science. The debate highlights tensions between environmental advocacy and energy policy.
The UK's science funding body plans to cut physics research, which critics argue will be disastrous for UK scientists and their participation in international projects like CERN. These cuts could diminish Britain's global standing in science.
The Ebola outbreak in the Democratic Republic of Congo has worsened, with over 200 suspected deaths reported, and the virus now poses a risk to ten other African countries. Health organizations are intensifying efforts to contain the spread, while some countries implement screening and quarantine measures for travelers from affected regions.
UK scientists have developed a new data tool that can identify individuals most at risk of obesity-related diseases, potentially helping the NHS prioritize access to limited weight-loss medication.
Scientists in the UK are developing a new Ebola vaccine that could be ready for use within a few months, offering a potential new tool in combating the deadly virus.
Scientists in the UK are planning to conduct experiments involving spraying seawater into the sky as a novel geoengineering technique. This initiative aims to mitigate climate change by increasing cloud reflectivity.